Literature DB >> 21127438

Vasomotor menopausal symptoms are associated with increased risk of coronary heart disease.

Gerrie-Cor M Gast1, Victor J M Pop, Göran N Samsioe, Diederick E Grobbee, Peter M Nilsson, Jules J Keyzer, Colette J M Wijnands-van Gent, Yvonne T van der Schouw.   

Abstract

OBJECTIVE: Emerging evidence suggests that women with vasomotor menopausal symptoms (VMS) may have an adverse cardiovascular disease (CVD) risk profile. We investigated whether VMS are related to an increased risk of future coronary heart disease (CHD) and whether possible associations can be explained by CVD risk factors.
METHODS: Data used were from a Dutch and Swedish population-based sample of 10,787 women enrolled between 1995 and 2000, aged 46 to 64 years, and free of CVD at baseline. Data on VMS were collected by questionnaires. Body mass index and blood pressure were measured in all women, and total cholesterol levels were measured in a subgroup of the population. Multivariable Cox regression models were used to analyze the data.
RESULTS: After a mean ± SD follow-up period of 10.3 ± 2.1 years, 303 women were diagnosed with CHD. Symptoms of flushing were not associated with risk of CHD. However, the presence of night sweats was associated with a significantly modest increased risk of CHD, with a multivariable-adjusted hazard ratio of 1.33 (95% CI, 1.05-1.69). This association was attenuated but not eliminated after correction for body mass index, blood pressure, and total cholesterol (hazard ratio, 1.25; 95% CI, 0.99-1.58).
CONCLUSIONS: Women with menopausal symptoms of night sweats have a significantly moderately increased risk of CHD, which cannot be totally explained by the levels of CVD risk factors.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21127438     DOI: 10.1097/gme.0b013e3181f464fb

Source DB:  PubMed          Journal:  Menopause        ISSN: 1072-3714            Impact factor:   2.953


  29 in total

1.  Decreased oxidant profile and increased antioxidant capacity in naturally postmenopausal women.

Authors:  V J Victorino; C Panis; F C Campos; R C Cayres; A N Colado-Simão; S R Oliveira; A C S A Herrera; A L Cecchini; R Cecchini
Journal:  Age (Dordr)       Date:  2012-05-28

2.  Vasomotor symptom characteristics: are they risk factors for incident diabetes?

Authors:  Kristen E Gray; Jodie G Katon; Erin S LeBlanc; Nancy F Woods; Lori A Bastian; Gayle E Reiber; Julie C Weitlauf; Karin M Nelson; Andrea Z LaCroix
Journal:  Menopause       Date:  2018-05       Impact factor: 2.953

3.  Are vasomotor symptoms associated with alterations in hemostatic and inflammatory markers? Findings from the Study of Women's Health Across the Nation.

Authors:  Rebecca C Thurston; Samar R El Khoudary; Kim Sutton-Tyrrell; Carolyn J Crandall; Ellen Gold; Barbara Sternfeld; Faith Selzer; Karen A Matthews
Journal:  Menopause       Date:  2011-10       Impact factor: 2.953

4.  Vasomotor symptoms and the risk of incident venous thrombosis in postmenopausal women.

Authors:  L B Harrington; M Blondon; M Cushman; A M Kaunitz; M A Allison; L Wang; S Sullivan; N F Woods; A Z LaCroix; S R Heckbert; B McKnight; J Rossouw; N L Smith
Journal:  J Thromb Haemost       Date:  2018-04-02       Impact factor: 5.824

Review 5.  Puberty and perimenopause: reproductive transitions and their implications for women's health.

Authors:  Lindsay Till Hoyt; April M Falconi
Journal:  Soc Sci Med       Date:  2015-03-14       Impact factor: 4.634

Review 6.  Vasomotor symptoms: natural history, physiology, and links with cardiovascular health.

Authors:  R C Thurston
Journal:  Climacteric       Date:  2018-02-02       Impact factor: 3.005

7.  Cardiovascular, hemodynamic, neuroendocrine, and inflammatory markers in women with and without vasomotor symptoms.

Authors:  Jennifer L Gordon; David R Rubinow; Rebecca C Thurston; Julia Paulson; Peter J Schmidt; Susan S Girdler
Journal:  Menopause       Date:  2016-11       Impact factor: 2.953

8.  Self-reported menopausal symptoms, coronary artery calcification, and carotid intima-media thickness in recently menopausal women screened for the Kronos early estrogen prevention study (KEEPS).

Authors:  Erin Foran Wolff; Yunxiao He; Dennis M Black; Eliot A Brinton; Mathew J Budoff; Marcelle I Cedars; Howard N Hodis; Rogerio A Lobo; Joann E Manson; George R Merriam; Virginia M Miller; Fredrick Naftolin; Lubna Pal; Nanette Santoro; Heping Zhang; S Mitchell Harman; Hugh S Taylor
Journal:  Fertil Steril       Date:  2013-01-08       Impact factor: 7.329

9.  Menopausal symptoms and cardiovascular disease mortality in the Women's Ischemia Syndrome Evaluation (WISE).

Authors:  Rebecca C Thurston; B Delia Johnson; Chrisandra L Shufelt; Glenn D Braunstein; Sarah L Berga; Frank Z Stanczyk; Carl J Pepine; Vera Bittner; Steven E Reis; Diane V Thompson; Sheryl F Kelsey; George Sopko; C Noel Bairey Merz
Journal:  Menopause       Date:  2017-02       Impact factor: 2.953

10.  What's in a name: are menopausal "hot flashes" a symptom of menopause or a manifestation of neurovascular dysregulation?

Authors:  Virginia M Miller; Juliana M Kling; Julia A Files; Michael J Joyner; Ekta Kapoor; Ann M Moyer; Walter A Rocca; Stephanie S Faubion
Journal:  Menopause       Date:  2018-06       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.